NCT05145751View on ClinicalTrials.gov

SARS CoV-2 Infection and Inflammatory Biomarkers

CompletedOBSERVATIONAL

Enrollment

115

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

January 31, 2022

Conditions

COVID-19Inflammation

Interventions

OTHER

Simple inflammatory biomarkers measurement

In patients with polymerase chain reaction (PCR) confirmed SARS CoV-2 infection the values of simple inflammatory biomarkers such NLR will be measured

Trial Locations (1)

41110

Univeristy of Thessaly, Larissa

All Listed Sponsors

lead

University of Thessaly

OTHER

NCT05145751 - SARS CoV-2 Infection and Inflammatory Biomarkers | Biotech Hunter | Biotech Hunter